Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Cardiovascular Endocrinology|September 9, 2017
Ready! Aim! Fire! targeting the right medical science journalTimothy C Hardman, James M SerginsonExpert Opinion on Investigational Drugs|April 13, 2012
Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemiaAnthony S Wierzbicki, Timothy C Hardman, Adie ViljoenCurrent Opinion in Cardiology|June 6, 2013
New therapies to reduce low-density lipoprotein cholesterolAnthony S Wierzbicki, Adie Viljoen, Timothy C Hardman, et al.Current Pharmaceutical Design|December 7, 2010
Sodium-glucose co-transporter 2 inhibitors: from apple tree to 'Sweet Pee'Timothy C Hardman, Peter Rutherford, Simon W Dubrey, et al.Drugs in Context|June 14, 2023
The future of clinical trials and drug development: 2050Timothy C Hardman, Rob Aitchison, Richard Scaife, et al.Chemmedchem|December 21, 2020
Action of Dipeptidyl Peptidase-4 Inhibitors on SARS-CoV-2 Main ProteaseHerbert Nar, Gisela Schnapp, Oliver Hucke, et al.Journal of Pharmacological and Toxicological Methods|October 22, 2002
Correction for the adverse influence of sodium-potassium cotransport on apparent sodium-lithium countertransport activity in human erythrocytesTimothy C Hardman, Zoë Morrish, Mayur Patel, et al.Current Medical Research and Opinion|January 23, 2008
HIV lipodystrophy and its metabolic consequences: implications for clinical practiceAnthony S Wierzbicki, Scott D Purdon, Timothy C Hardman, et al.British Journal of Clinical Pharmacology|March 8, 2026
Why do healthy volunteers participate in clinical trials?Thijs van Iersel, Jelle Klein, Timothy C Hardman, et al.Frontiers in Pharmacology|November 29, 2023
Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challengesCharles Mundy, James Bush, Joseph Cheriyan, et al.Pageof 3